Published in J Am Soc Nephrol on November 07, 2014
Immune Monitoring as Prerequisite for Transplantation Tolerance Trials. Clin Exp Immunol (2017) 0.84
Recent advances in renal transplantation: antibody-mediated rejection takes center stage. F1000Prime Rep (2015) 0.83
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen. Front Immunol (2016) 0.79
Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation. Front Immunol (2016) 0.78
Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies. Transplantation (2017) 0.77
The Complement System and Antibody-Mediated Transplant Rejection. J Immunol (2015) 0.76
Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications. J Immunol Res (2017) 0.75
Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians. Transplantation (2016) 0.75
Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation. Front Immunol (2017) 0.75
Renal allograft rejection: pieces of the puzzle. J Am Soc Nephrol (2014) 0.75
Unraveling the Role of Allo-Antibodies and Transplant Injury. Front Immunol (2016) 0.75
Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection. J Immunol Res (2017) 0.75
Transplant genetics and genomics. Nat Rev Genet (2017) 0.75
Advances in diagnostics for transplant rejection. Expert Rev Mol Diagn (2016) 0.75
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A (2002) 25.47
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant (2009) 2.27
Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science (2008) 2.10
Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet (2005) 2.02
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol (2012) 1.71
Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54
Robust-linear-model normalization to reduce technical variability in functional protein microarrays. J Proteome Res (2009) 1.29
Using real data for a virtual crossmatch. Hum Immunol (2009) 1.23
In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody. Circ Res (2008) 1.17
Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation (2009) 1.05
Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury. J Am Soc Nephrol (2012) 1.05
Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol (1997) 1.03
Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells. Hum Immunol (2000) 0.98
Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation. J Proteome Res (2010) 0.92
Importance of molecular studies on major blood groups--intercellular adhesion molecule-4, a blood group antigen involved in multiple cellular interactions. Biochim Biophys Acta (2007) 0.89
Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. Transplantation (2011) 0.89
Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody. Am J Transplant (2012) 0.86
CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization. Kidney Int (2004) 0.85
Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant (2009) 0.85
Immune response profiling identifies autoantibodies specific to Moyamoya patients. Orphanet J Rare Dis (2013) 0.84
Moving beyond HLA: a review of nHLA antibodies in organ transplantation. Hum Immunol (2013) 0.83
Endoglin regulates renal ischaemia-reperfusion injury. Nephrol Dial Transplant (2006) 0.81
HLA class I antibody-mediated endothelial and smooth muscle cell activation. Curr Opin Organ Transplant (2012) 0.80
A flow cytometric crossmatch test using endothelial precursor cells isolated from peripheral blood. Methods Mol Biol (2013) 0.79